GlassScriptPhysician profile
Jeffrey R Lyman
NPI 1316945876
$17,405.86
in general payments reported to CMS, 2019-2025
12 companies · $70.66 in 2025
The $70.66 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,428 · 2020: $338 · 2021: $6,745 · 2022: $4,834 · 2023: $629 · 2024: $3,361 · 2025: $70.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,738 · Food and Beverage: $1,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,738.06 |
| Food and Beverage | $1,322.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $8,305.04 | 2019-2022 | |
| Stryker Corporation | $7,950.35 | 2019-2025 | Mako, Triathlon, Avon |
| Smith+Nephew, INC. | $393.69 | 2021-2023 | Firstpass, Ultrabutton, Na |
| Tracpatch Health, INC | $250.00 | 2019 | |
| Medacta USA, INC. | $144.00 | 2019 | |
| Ortho Development Corporation | $132.50 | 2023 | |
| Depuy Synthes Sales INC. | $124.95 | 2019-2021 | |
| Nalu Medical, INC. | $34.39 | 2023 | Nalu Neurostimulation System |
| Fidia Pharma USA INC. | $22.09 | 2019 | |
| Horizon Therapeutics Plc | $18.67 | 2020 | |
| Arthrex, INC. | $16.00 | 2021 | |
| Ferring Pharmaceuticals INC. | $14.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lyman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.